KAD-1229

DRUG2 trials

Sponsors

Kissei Pharmaceutical Co., Ltd.

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 3

Long-term Study of KAD-1229 in Type 2 Diabetes Patients

CompletedNCT01333592

Kissei Pharmaceutical Co., Ltd.Type 2 Diabetes

End: 2012-11-30Updated: 2014-12-15

Phase 4

Post-marketing Clinical Trial of KAD-1229 in Patients With Type 2 Diabetes Mellitus

CompletedNCT02154347

Kissei Pharmaceutical Co., Ltd.Type 2 Diabetes Mellitus

Updated: 2019-09-06

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01